Table 2.
Characteristics | No sarcopenia | Sarcopenia | p |
---|---|---|---|
AWGS | n = 323 | n = 61 | |
PLR | 94.3 ± 39.5 | 101.6 ± 40.6 | 0.190 |
NLR | 2.1 ± 0.9 | 2.1 ± 0.8 | 0.828 |
LMR | 4.4 ± 1.3 | 4.4 ± 1.5 | 0.939 |
AWGS 2019 | n = 208 | n = 176 | |
PLR | 93.7 ± 35.5 | 97.5 ± 44.2 | 0.348 |
NLR | 2.1 ± 0.8 | 2.1 ± 1.0 | 0.407 |
LMR | 4.4 ± 1.5 | 4.4 ± 1.6 | 0.757 |
EWGSOP | n = 339 | n = 45 | |
PLR | 94.2 ± 39.6 | 105.3 ± 39.4 | 0.079 |
NLR | 2.1 ± 0.9 | 2.3 ± 1.2 | 0.078 |
LMR | 4.5 ± 1.5 | 4.1 ± 1.5 | 0.141 |
EWGSOP2 | n = 346 | n = 38 | |
PLR | 94.5 ± 39.7 | 104.3 ± 38.9 | 0.149 |
NLR | 2.1 ± 0.9 | 2.3 ± 1.1 | 0.177 |
LMR | 4.4 ± 1.5 | 4.4 ± 1.6 | 0.909 |
IWGS | n = 288 | n = 96 | |
PLR | 94.1 ± 38.6 | 99.7 ± 42.9 | 0.228 |
NLR | 2.1 ± 0.9 | 2.1 ± 0.9 | 0.758 |
LMR | 4.4 ± 1.5 | 4.4 ± 1.5 | 0.884 |
FNIH | n = 325 | n = 59 | |
PLR | 96.1 ± 40.2 | 92.1 ± 37.1 | 0.484 |
NLR | 2.1 ± 0.9 | 1.9 ± 0.8 | 0.178 |
LMR | 4.4 ± 1.5 | 4.7 ± 1.4 | 0.078 |
Abbreviations: AWGS Asia Working Group for Sarcopenia, AWGS 2019 the updated version of AWGS, EWGSOP European Working Group on Sarcopenia in Older People, EWGSOP2 the updated version of EWGSOP, FNIH the Foundation for the National Institutes of Health, IWGS International Working Group on Sarcopenia, LMR lymphocyte-to-monocyte ratio, NLR neutrophil-to-lymphocyte ratio, PLR platelet-to-lymphocyte ratio